Frazier Management as of Sept. 30, 2018
Portfolio Holdings for Frazier Management
Frazier Management holds 16 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 42.3 | $231M | 2.3M | 99.77 | |
| Aptinyx | 16.9 | $92M | 3.2M | 28.96 | |
| Allena Pharmaceuticals | 6.5 | $36M | 3.3M | 10.74 | |
| Gritstone Oncology Ord (GRTSQ) | 5.4 | $29M | 2.1M | 14.24 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 5.1 | $28M | 1.9M | 14.74 | |
| Iovance Biotherapeutics (IOVA) | 4.5 | $25M | 2.2M | 11.25 | |
| Entasis Therapeutics Holdings Ord | 2.7 | $15M | 1.3M | 10.88 | |
| Alpine Immune Sciences | 2.5 | $14M | 2.2M | 6.33 | |
| Sierra Oncology | 2.5 | $14M | 8.1M | 1.70 | |
| Synlogic | 2.2 | $12M | 865k | 14.21 | |
| Nabriva Therapeutics | 2.1 | $12M | 4.3M | 2.70 | |
| Krystal Biotech (KRYS) | 2.0 | $11M | 625k | 17.58 | |
| Iterum Therapeutics | 1.9 | $10M | 1.5M | 6.70 | |
| Bellicum Pharma | 1.2 | $6.5M | 1.1M | 6.16 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.1 | $5.8M | 1.3M | 4.40 | |
| Kezar Life Sciences | 1.0 | $5.4M | 250k | 21.41 |
